BC
KIDS icon

Birchview Capital’s OrthoPediatrics KIDS Stock Holding History

Birchview Capital’s Portfolio KIDS Stock Details KIDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,000
Closed -$296K – 74
2025
Q3 		$296K Sell
16,000
-10,000
-38% -$206K 0.22% 60
2025
Q2 		$558K Buy
26,000
+6,000
+30% +$130K 0.55% 40
2025
Q1 		$493K Buy
+20,000
New +$494K 0.43% 33

Other funds holding KIDS

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Birchview Capital's KIDS Position: Q4 2025 in Review

Birchview Capital sold out of OrthoPediatrics (KIDS) in Q4 2025, closing a stake of 16,000 shares — an estimated $296K sold.

Birchview Capital first reported a position in KIDS in Q1 2025 and held it in 3 quarters. The position peaked at $558K in Q2 2025. 120 funds tracked by Wall St. Rank hold KIDS as of Q4 2025.

  • Birchview Capital reported no remaining OrthoPediatrics position as of Q4 2025 after selling out during the quarter.
  • Birchview Capital sold 16,000 OrthoPediatrics shares in Q4 2025, an estimated $296K.
  • Birchview Capital first reported a position in OrthoPediatrics in Q1 2025 and held it in 3 quarters.
  • Birchview Capital's OrthoPediatrics position peaked at $558K in Q2 2025.
  • 120 funds tracked by Wall St. Rank held OrthoPediatrics as of Q4 2025.

Based on Birchview Capital's 13F filing for Q4 2025, filed 13 Feb 2026.